Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 385,191 | 397,815 | 376,638 | 405,524 | 386,861 |
| Cost of Goods | 148,445 | 148,404 | 142,569 | 156,250 | 144,468 |
| Gross Profit | 236,746 | 249,411 | 234,069 | 249,274 | 242,393 |
| Operating Expenses | 172,142 | 189,948 | 188,474 | 191,301 | 186,422 |
| Operating Income | 65,049 | 59,867 | 46,164 | 58,223 | 56,439 |
| Interest Expense | 12,809 | 12,236 | 11,655 | 12,125 | 12,192 |
| Other Income | 6,556 | 3,944 | 4,806 | 5,689 | 6,541 |
| Pre-tax Income | 58,796 | 51,575 | 39,315 | 51,787 | 50,788 |
| Income Tax | 8,881 | 6,787 | 6,414 | 6,403 | 7,559 |
| Net Income Continuous | 49,915 | 44,788 | 32,901 | 45,384 | 43,229 |
| Net Income | $49,915 | $44,788 | $32,901 | $45,384 | $43,229 |
| EPS Basic Total Ops | 0.60 | 0.54 | 0.39 | 0.54 | 0.51 |
| EPS Basic Continuous Ops | 0.60 | 0.54 | 0.39 | 0.53 | 0.51 |
| EPS Diluted Total Ops | 0.60 | 0.54 | 0.39 | 0.53 | 0.51 |
| EPS Diluted Continuous Ops | 0.60 | 0.54 | 0.39 | 0.53 | 0.51 |
| EBITDA(a) | $96,266 | $91,147 | $77,612 | $90,691 | $88,300 |